Women and Heart Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Microvascular Coronary Disease In Women: Impact Of Ranolazine

Condition:   Myocardial Ischemia
Interventions:   Drug: Ranolazine;   Drug: Placebo
Sponsors:   Cedars-Sinai Medical Center;   CV Therapeutics

Effect of Mental Stress on Myocardial Perfusion in Women

Condition:   Non-Obstructive Coronary Atherosclerosis
Intervention:   Diagnostic Test: Mental Stress Test
Sponsor:   Guangdong General Hospital
Not yet recruiting

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Condition:   Coronary Artery Disease
Interventions:   Drug: High dose potent statin;   Drug: ACE-I (lisinopril) or ARB (losartan);   Drug: Aspirin;   Behavioral: Lifestyle Counseling;   Behavioral: Quality of Life Questionnaires
Sponsors:   University of Florida;   United States Department of Defense

Peer Support for Women With Heart Disease: Women@Heart

Conditions:   Coronary Heart Disease;   Women's Health
Intervention:   Behavioral: Women@Heart Program
Sponsor:   Ottawa Heart Institute Research Corporation

Insulin Resistance and Atherosclerosis in Women With Lupus

Conditions:   Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Walking Training in Peripheral Artery Disease (GrEnADa Sub-study)

Conditions:   Peripheral Artery Disease;   Intermittent Claudication
Interventions:   Other: Stretching exercise group;   Other: Walking training group
Sponsor:   KU Leuven


Condition:   Coronary Artery Disease
Interventions:   Drug: 3 months of dual antiplatelet therapy (DAPT);   Device: SYNERGY Stent System
Sponsor:   Boston Scientific Corporation
Active, not recruiting

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Conditions:   Coronary Artery Disease;   Ischemic Heart Disease;   Non ST Segment Elevation Myocardial Infarction
Interventions:   Device: Orbital Atherectomy;   Device: Balloon
Sponsors:   Cardiovascular Systems Inc;   Cardiovascular Research Foundation, New York